Bonnet-Dechaume-Blanc syndrome: Difference between revisions
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
[[Bonnet-Dechaume-Blanc syndrome]] or Wyburn mason's syndrome or Retinoencephalofacial [[angiomatosis]] is a rare [[arteriovenous malformation]] ([[Arteriovenous malformation|AVMs]]) condition. In The United States of America in order to categorise a [[condition]] as a [[rare disease]] it should affect fewer than 200,000 people. [[Rare diseases]] also called as [[Orphan disease|orphan diseases]]. [[Orphan Drug Act]] was passed on 1983 by congress for the [[rare diseases]]. Today an average of 25-30 million americans have been reported with [[rare diseases]]. The number of people with individual [[rare disease]] may be less but overall the number of people with [[rare diseases]] are large in number. | [[Bonnet-Dechaume-Blanc syndrome]] or Wyburn mason's syndrome or Retinoencephalofacial [[angiomatosis]] is a rare [[arteriovenous malformation]] ([[Arteriovenous malformation|AVMs]]) condition. In The United States of America in order to categorise a [[condition]] as a [[rare disease]] it should affect fewer than 200,000 people. [[Rare diseases]] also called as [[Orphan disease|orphan diseases]]. [[Orphan Drug Act]] was passed on 1983 by congress for the [[rare diseases]]. Today an average of 25-30 million americans have been reported with [[rare diseases]]. The number of people with individual [[rare disease]] may be less but overall the number of people with [[rare diseases]] are large in number. | ||
== Historical Perspective == | |||
== Signs and symptoms == | == Signs and symptoms == | ||
== Causes == | == Causes == | ||
Revision as of 12:02, 5 June 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Synonyms and keywords: Wyburn mason's syndrome; Retinoencephalofacial angiomatosis
Overview
Bonnet-Dechaume-Blanc syndrome or Wyburn mason's syndrome or Retinoencephalofacial angiomatosis is a rare arteriovenous malformation (AVMs) condition. In The United States of America in order to categorise a condition as a rare disease it should affect fewer than 200,000 people. Rare diseases also called as orphan diseases. Orphan Drug Act was passed on 1983 by congress for the rare diseases. Today an average of 25-30 million americans have been reported with rare diseases. The number of people with individual rare disease may be less but overall the number of people with rare diseases are large in number.